AMANDA MCCLENDON: Open Payments
NPI 1831427228 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,028 in 28 payments from 8 companies in 2025. Trend: 2023 $217 · 2024 $1,035 · 2025 $1,028
Food & beverage: $1,028
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $375 |
| Novo Nordisk Inc | 10 | $339 |
| Novartis Pharmaceuticals Corporation | 6 | $139 |
| HEARTFLOW, INC. | 2 | $82 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: Wegovy, REPATHA, Ozempic, LEQVIO, FFRct, NEXLETOL, EVKEEZA, WATCHMAN Access System.
Industry payments across PA — which companies pay providers there.
